A Study to Evaluate BMS-986278 in Participants With Normal Renal Function, Severe Renal Impairment, or End-Stage Renal Disease on Intermittent Hemodialysis

NCT06723535 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Failure, Chronic
Healthy Volunteers
Renal Impairment

Interventions

DRUG: BMS-986278

Sponsor

Bristol-Myers Squibb